CLINICAL_TRIALS
trial_result
· 2022-11-02
Clinical Trial Update: SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" [Phase 4]
Summary
A Phase 4 trial assessing the effect of Dupixent (dupilumab) on sleep in adults with atopic dermatitis has completed, with results posted in November 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2022-11-02